HOME >> BIOLOGY >> NEWS
Salmonella Vaccine Now Available For Poultry

A vaccine invented by a biologist at Washington University in St. Louis has received federal approval for use in controlling Salmonella bacteria in poultry.

Megan Health Inc., a St. Louis based vaccine discovery company, has been granted a United States Department of Agriculture (USDA) license for a vaccine that controls Salmonella contamination of poultry products.

The new vaccine, Megan™Vac 1, is applied to baby chicks via spray in the hatchery. The vaccine stimulates immunity in the chickens, preventing Salmonella infection during the growing period which may result in contamination and subsequent food borne infection of humans.

In recently completed trials on US commercial broiler farms which included more than a million pounds of chicken, Megan™Vac 1 eliminated Salmonella on dressed chicken. Ten percent of the non-vaccinated chickens in these trials were contaminated.

The US broiler chicken industry has improved their processed chicken contamination rate greatly in the past few years moving from 50% positive in the 1980's to 20% positive two years ago to 10% this past year (according to tests reported by USDA's Food Safety Inspection Service). " Our new vaccine is a remarkable tool which will help broiler producers reach their goal of 0 % contamination." says David Zacek, President of Megan Health Animal Health Division.

The new vaccine, more than 4.5 years in development, is the invention of Roy Curtiss III, Ph.D., professor of biology at Washington University and founder of Megan Health, Inc.

"This vaccine is designed to live only long enough to stimulate an immune response in chickens and then is eliminated by the chickens' immune system to assure food safety at processing. It is very specific for Salmonella control, very low cost at less than one cent per bird and is easily applied using traditional techniques now used by US broiler chicken production companies." according to Sandra Kelly, MS, Biologicals Deve
'"/>

Contact: Tony Fitzpatrick
tony_fitzpatrick@aismail.wustl.edu
314-935-5272
Washington University in St. Louis
3-Dec-1998


Page: 1 2

Related biology news :

1. Salmonella infects cells and saves itself by altering host membrane lipids
2. Salmonella uses molecular staples to change structure of infected cells
3. Vion Demonstrates Readiness Of First Tumor-Targeting Salmonella For Human Testing Against Solid Tumors
4. Researchers Identify Key Gene That Controls Emergence Of Salmonella
5. DT104 Advice:How To Slow Salmonella Spread
6. First Salmonella Vaccine For Poultry To Be On The Market Soon
7. Hope Clinic of Emory Vaccine Center receives CDC contract
8. Vaccines against foodborne disease on horizon
9. GenVec, U.S. NMRC, and PATHs Malaria Vaccine Initiative partner to expand malaria vaccine efforts
10. Vaccine technique shows potential against common form of lung cancer
11. Fighting fire with fire? Vaccine based on chimp virus shows promise against HIV

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Salmonella Vaccine Now Available For Poultry

(Date:7/31/2014)... brown and beige adipocytes, or fat cells, are inherently ... and each plays its own role in metabolism. In ... the most prevalent. Its primary function is energy storage. ... to generate heat but are only found in a ... which represent a special type of brown adipocytes, appear ...
(Date:7/30/2014)... University is paving the way for a breakthrough ... military troops exposed to poisonous chemicalsparticularly those in ... in the current issue of the journal ... which are compounds commonly used in pesticides and ... NYU School of Engineering Associate Professor of Chemical ...
(Date:7/30/2014)... change on the world,s animal and plant species ... a new paper by a research team from ... other organizations. The authors claim that most of ... it comes to climate change. , While ... the "direct" threats of changing temperatures and precipitation ...
Breaking Biology News(10 mins):Hope for the overweight 2Engineering a protein to prevent brain damage from toxic agents 2Conservation scientists asking wrong questions on climate change impacts on wildlife 2
(Date:7/31/2014)... 31, 2014   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade hypothermic storage ... thermal shipping products for cells and tissues, today ... results will be released on Thursday, August 7, 2014, ... and live webcast at 4:30 p.m. ET that afternoon. ...
(Date:7/31/2014)... Boston’s Adult Stem Cell Technology Center, LLC ( ... cell biotechnologies. Currently the company holds seven recently ... applications currently under examination by the U.S. Patent and ... the most vexing problems in adult stem cell biology ... difficult to identify; and they have been difficult to ...
(Date:7/30/2014)... and PARIS , July 30, ... (EURONEXT: SAN and NYSE: SNY) today announced that the ... Administration (FDA) rare pediatric disease priority review voucher in ... alirocumab.  The priority review voucher entitles the holder to ... an expedited 6-month review from the filing date instead ...
(Date:7/30/2014)... 30, 2014 A study presented at ... and efficacy of CSL Behring,s C1 Inhibitor (C1-INH) ... in highly sensitized patients. C1-INH is a human ... system. The study shows that post-transplant ... the levels of complement components 3 and 4, ...
Breaking Biology Technology:BioLife Solutions to Report Financial Results for Second Quarter 2014 and Provide Business Update on August 7, 2014 2The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies 2The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 5Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 6Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 2Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 3
Cached News: